Insider Transactions Reported by 23 Insiders of HAEMONETICS CORP

Symbol
HAE on NYSE
Location
Boston, MA

Insiders trading volume in the past year

HAEMONETICS CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Simon President & CEO, Director $26.1M 30 May 2025
Josep Llorens EVP, Global Manufacturing $2.96M 28 May 2024
William Burke EVP, Chief Financial Officer $2.62M 23 Aug 2021
Michelle L. Basil EVP and General Counsel $2.2M 30 May 2025
James DArecca EVP, Chief Financial Officer $1.96M 30 May 2025
Anila Lingamneni EVP, Chief Technology Officer $1.92M 11 Jul 2024
Charles J. Dockendorff Director $1.87M 24 Jul 2025
ROBERT E. ABERNATHY Director $1.86M 24 Jul 2025
MARK W. KROLL Director $1.75M +$98.8K +5.99% 10 Nov 2025
CATHERINE M. BURZIK Director $1.69M 05 Aug 2022
Stewart W. Strong President, Global Hospital $1.66M 26 Jul 2024
Chad M. Nikel President, Global Plasma & BC $1.5M 06 Aug 2021
Ellen M. Zane Director $1.45M 24 Jul 2025
Laurie A. Miller SVP, Human Resources $1.44M 17 Sep 2025
Claire Pomeroy Director $1.26M 24 Jul 2025
MICHAEL J. COYLE Director $1.15M 24 Jul 2025
Lloyd Emerson Johnson Director $965K 24 Jul 2025
Roy Galvin EVP, Chief Commercial Officer $641K 31 Oct 2025
Diane M. Bryant Director $532K 24 Jul 2025
Dan Goldstein VP, Corporate Controller $384K 13 Jun 2022
Jacqueline Scanlan SVP, Global Human Resources $364K 07 Jun 2021
Frank Chan EVP, Chief Operating Officer $352K 16 May 2025
Farris Maryanne Maunsell VP, Chief Accounting Officer $280K 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for HAEMONETICS CORP

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.